Amlodipine Besylate
Who holds supplier records for Amlodipine Besylate? 32 organisations hold a current record for Amlodipine Besylate: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 24 of them hold a valid EU Certificate of Suitability (25 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (21), United States (2), Hungary (2), Spain (1) and 3 other countries (3); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Amlodipine Besylate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/amlodipine-besylate
Reading the evidence
- 32 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
21 of the 29 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 21 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (32)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Amlodipine Besylate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- GLOCHEM INDUSTRIES LTDIndiaCEPActive DMF 24942, 19591, 27810 · latest filing Dec 2013
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 40438, 16509 · latest filing Aug 2024
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 22930, 18827 · latest filing Jul 2009
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 18965 · latest filing Nov 2005
- Arene Life Sciences LimitedIndiaCEPActive DMF 33873, 35997 · latest filing Jun 2021
- Aurore Life SciencesIndiaCEP Company GMP cert on recordActive DMF 34318 · latest filing Nov 2019
- Cadila Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 16911 · latest filing Sept 2003
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 17032 · latest filing Dec 2003
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 16473 · latest filing Mar 2003
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 18787, 16478, 30717 · latest filing Jul 2016
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 23589 · latest filing Jul 2010
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 20112 · latest filing Jan 2007
- MOEHS IBERICA SLSpainCEPActive DMF 17070 · latest filing Dec 2003
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 28886 · latest filing Feb 2015
- Alkem Laboratories LimitedIndia Company GMP cert on recordActive DMF 29703 · latest filing Sept 2015
- ARCH PHARMALABS LTDIndiaActive DMF 23632 · latest filing May 2010
- LEE PHARMA LTDIndia Company GMP cert on recordActive DMF 43701 · latest filing Feb 2026
- Lupin LimitedIndia Company GMP cert on recordActive DMF 18839 · latest filing Oct 2005
- NOVARTIS PHARMACEUTICALS CORPUnited States Company GMP cert on recordActive DMF 22964 · latest filing Jul 2009
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 19582 · latest filing Jul 2006
- SRINI PHARMACEUTICALS PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 22622 · latest filing Mar 2009
- TAPI NL BVNetherlandsActive DMF 15777 · latest filing Dec 2001
- CHANGZHOU RUIMING PHARMACEUTICAL CO LTDCEPInactive DMF 21256 · latest filing Jan 2008
- Egis Pharmaceuticals PLCHungaryCEP Company GMP cert on recordInactive DMF 27964 · latest filing Jan 2014
- ESTEVE QUIMICA SACEP Company GMP cert on recordInactive DMF 15127, 22342 · latest filing Dec 2008
- Gedeon RichterHungaryCEP Company GMP cert on recordInactive DMF 17584 · latest filing Aug 2004
- IndiaCEP
- NOVARTIS PHARMA AGCEP Company GMP cert on record
- Smruthi Organics LimitedIndiaCEP Company GMP cert on recordInactive DMF 20916 · latest filing Oct 2007
- United StatesCEP
- RAGHAVA LIFE SCIENCES PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- KRKA, d.d.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (25)
Certificates of Suitability on the EDQM register for Amlodipine Besylate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 53 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| RAGHAVA LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2023-350 - Rev 01 Amlodipine besilate | Sept 2026 | — |
| AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2019-310 - Rev 03 Amlodipine besilate | Sept 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2025-407 - Rev 01 Amlodipine besilate, Site-II | Sept 2026 | — |
| SMRUTHI ORGANICS LIMITED Solapur | IN | CEP 2023-393 - Rev 01 Amlodipine besilate | Jun 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2006-119 - Rev 07 Amlodipine besilate | May 2026 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2006-130 - Rev 06 Amlodipine besilate | Mar 2026 | — |
| KOPRAN RESEARCH LABORATORIES LIMITED Mumbai | IN | CEP 2021-242 - Rev 01 Amlodipine besilate | Mar 2026 | — |
| MOEHS IBERICA S.L. Rubi | ES | CEP 2021-359 - Rev 03 Amlodipine besilate, M02 | Mar 2026 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2025-166 - Rev 01 Amlodipine besilate, TY 45 | Mar 2026 | — |
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2024-371 - Rev 01 Amlodipine besilate, ADP process | Feb 2026 | — |
| EGIS Pharmaceuticals PLC Budapest X | HU | CEP 2023-411 - Rev 01 Amlodipine besilate, Synthesis B process B | Feb 2026 | Inspected Nov 2025 Hungary |
| NOVARTIS PHARMA AG Basel | CH | CEP 2008-122 - Rev 03 Amlodipine besilate, Process II | Feb 2026 | Inspected Dec 2025 Switzerland |
| CIPLA LIMITED Mumbai | IN | CEP 2015-140 - Rev 02 Amlodipine besilate, Process II | Feb 2026 | — |
| ARENE LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2020-371 - Rev 05 Amlodipine besilate, Process-I | Dec 2025 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2016-282 - Rev 01 Amlodipine besilate, Micronised and non-micronised | Nov 2025 | Inspected May 2026 Italy |
| VIATRIS SPECIALTY LLC Morgantown | US | CEP 2021-215 - Rev 01 Amlodipine besilate, Process C | Jan 2024 | — |
| GLOCHEM INDUSTRIES PRIVATE LIMITED Hyderabad | IN | CEP 2002-072 - Rev 10 Amlodipine besilate | Oct 2023 | — |
| IPCA Laboratories Limited Mumbai | IN | R0-CEP 2023-139 - Rev 00 Amlodipine besilate, AK4 process | Jul 2023 | — |
| KRKA, d.d., Novo mesto Novo mesto | SI | R0-CEP 2022-449 - Rev 00 Amlodipine besilate, 311302 | Jan 2023 | — |
| GEDEON RICHTER PLC. Budapest | HU | R1-CEP 2010-318 - Rev 01 Amlodipine besilate, RTML process | Aug 2022 | — |
| ZYDUS LIFESCIENCES LIMITED Ankleshwar | IN | R1-CEP 2007-280 - Rev 08 Amlodipine besilate | Jul 2022 | — |
| CHANGZHOU RUIMING PHARMACEUTICAL CO., LTD. Chunjiang Town | CN | R1-CEP 2008-074 - Rev 01 Amlodipine besilate | Mar 2022 | — |
| CADILA PHARMACEUTICALS LIMITED Ankleshwar | IN | R1-CEP 2007-293 - Rev 02 Amlodipine besilate | Feb 2021 | — |
| ESTEVE QUIMICA S.A. Barcelona | ES | R1-CEP 2008-073 - Rev 02 Amlodipine besilate | Oct 2020 | — |
| EGIS Pharmaceuticals PLC Budapest | HU | R1-CEP 2007-185 - Rev 02 Amlodipine besilate, Synthetic route B | Dec 2016 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Amlodipine Besylate are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 28351 · filed Jun 2014
- China · Inactive DMF 26132 · filed May 2012
- ALP PHARM BEIJING CO LTDInactive DMF 21951 · filed Sept 2008
- EOS ECZACIBASI OZGUN KIMYASAL URUNLER SANAYI VE TICARET ASInactive DMF 20277 · filed Feb 2007
- China · Inactive DMF 19043 · filed Dec 2005
- Netherlands · Inactive DMF 18872 · filed Oct 2005
- MYLAN LABORATORIES LTDInactive DMF 17211, 18503 · filed Jul 2005
- Slovenia · Inactive DMF 16887 · filed Oct 2003
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Amlodipine Besylate is a calcium channel blocker used to treat high blood pressure and angina. By relaxing blood vessels, it helps improve blood flow and reduce the heart's workload.
Chemical identity
- IUPAC name
- benzenesulfonic acid;3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
- Canonical SMILES
- CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O
- InChIKey
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N
- Synonyms
- amlessa component amlodipine besylate, amlodipine (as besilate), amlodipine benzenesulfonate, amlodipine besilate, amlor, amturnide component amlodipine besylate, antacal, azor component amlodipine besylate, caduet component amlodipine besylate, consensi component amlodipine besylate, copalia component amlodipine besylate, dafiro component amlodipine besilate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker
- Mechanism of action
- Calcium Channel Antagonists; Cytochrome P450 3A Inhibitors
- Chemical structure
- Dihydropyridines
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Amlodipine Besylate?
32 organisations hold an active US FDA Type II Drug Master File or a CEP for Amlodipine Besylate: GLOCHEM INDUSTRIES LTD (India), Unichem Laboratories Ltd. (India), Zydus Lifesciences Limited (India), APITORIA PHARMA PRIVATE LTD (India), Arene Life Sciences Limited (India), Aurore Life Sciences (India), Cadila Pharmaceuticals Limited (India) and Cipla Limited (India), and 24 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Amlodipine Besylate Drug Master Files are active?
GLOCHEM INDUSTRIES LTD (DMF 24942, 19591), Unichem Laboratories Ltd. (DMF 40438, 16509), Zydus Lifesciences Limited (DMF 22930, 18827), APITORIA PHARMA PRIVATE LTD (DMF 18965), Arene Life Sciences Limited (DMF 33873, 35997), Aurore Life Sciences (DMF 34318), Cadila Pharmaceuticals Limited (DMF 16911) and Cipla Limited (DMF 17032) and 14 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Amlodipine Besylate records mean?
8 organisations have only inactive Type II DMFs for Amlodipine Besylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Amlodipine Besylate have a European Certificate of Suitability?
Yes. 24 organisations hold a valid CEP for Amlodipine Besylate on the EDQM register, including RAGHAVA LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), HETERO DRUGS LIMITED Hyderabad (IN), SMRUTHI ORGANICS LIMITED Solapur (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN) and APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and 19 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Amlodipine Besylate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Amlodipine Besylate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.